This inventor holds 3 USPTO granted patents. Top assignees: Dana-Farber-Cancer Institute Inc., Other. Active years: 1998-1999.
Location History:
- Cambridge, MA (US) (1998 - 1999)
- Houston, TX (US) (1999)
Company Filing History:
2 out of 1,264 
1 out of 834,350 Years Active: 1998-1999
Title: Shideng Bao: Innovator in Tumor Marker Research
Introduction
Shideng Bao is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, particularly in the development of novel tumor markers. With a total of 3 patents, his work has the potential to impact cancer diagnostics and treatment.
Latest Patents
One of his latest patents is focused on monoclonal antibodies to the tumor marker TC1 and methods for their use. This invention encompasses a novel tumor marker that is present on tumor cells but absent on corresponding normal cells. Additionally, it includes nucleic acids encoding the tumor marker and a novel method for isolating DNA that encodes the tumor marker or a gene that is differentially expressed in tissues.
Career Highlights
Shideng Bao has worked at the Dana-Farber Cancer Institute Inc., where he has been involved in groundbreaking research. His work has contributed to advancements in understanding tumor biology and developing targeted therapies.
Collaborations
Throughout his career, Shideng Bao has collaborated with notable colleagues, including Lan Bo Chen and Yuan Liu. These collaborations have further enriched his research and innovation in the field.
Conclusion
Shideng Bao's contributions to tumor marker research exemplify the importance of innovation in cancer diagnostics and treatment. His patents and collaborations highlight his commitment to advancing medical science.